Oslo - Delayed Quote NOK
Lytix Biopharma AS (LYTIX.OL)
At close: 4:25 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
14,443.00
3,991.00
11,031.00
19,307.00
3.00
Operating Expense
92,869.00
100,776.00
76,696.00
67,293.00
42,375.00
Operating Income
-78,426.00
-96,785.00
-65,665.00
-47,986.00
-42,372.00
Net Non Operating Interest Income Expense
2,887.00
4,879.00
1,875.00
78.00
355.00
Pretax Income
-76,419.00
-87,897.00
-56,069.00
-48,079.00
-42,088.00
Net Income Common Stockholders
-76,419.00
-87,897.00
-56,069.00
-48,079.00
-42,088.00
Diluted NI Available to Com Stockholders
-76,419.00
-87,897.00
-56,069.00
-48,079.00
-42,088.00
Basic EPS
-1.79
-2.19
-1.41
-1.45
-1.09
Diluted EPS
-1.79
-2.19
-1.41
-1.45
-1.09
Basic Average Shares
42,453.82
40,068.32
39,667.71
33,194.65
38,739.01
Diluted Average Shares
42,453.82
40,068.32
39,667.71
33,194.65
38,739.01
Total Operating Income as Reported
-78,426.00
-96,785.00
-65,666.00
-47,985.00
-42,372.00
Total Expenses
92,869.00
100,776.00
76,696.00
67,293.00
42,375.00
Net Income from Continuing & Discontinued Operation
-76,419.00
-87,897.00
-56,069.00
-48,079.00
-42,088.00
Normalized Income
-76,419.00
-87,897.00
-56,069.00
-48,079.00
-42,088.00
Interest Income
1,370.00
2,351.00
1,406.00
138.00
347.00
Interest Expense
31.00
56.00
146.00
66.00
--
Net Interest Income
2,887.00
4,879.00
1,875.00
78.00
355.00
EBIT
-76,388.00
-87,841.00
-55,923.00
-48,013.00
-42,088.00
EBITDA
-75,432.00
-86,879.00
-55,004.00
-47,560.00
-42,088.00
Reconciled Depreciation
956.00
962.00
919.00
453.00
--
Net Income from Continuing Operation Net Minority Interest
-76,419.00
-87,897.00
-56,069.00
-48,079.00
-42,088.00
Normalized EBITDA
-75,432.00
-86,879.00
-55,004.00
-47,560.00
-42,088.00
12/31/2020 - 6/14/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PCIB.OL PCI Biotech Holding ASA
1.6500
+0.86%
BGBIO.OL BerGenBio ASA
7.22
-6.81%
ULTI.OL Ultimovacs ASA
1.8500
+6.94%
CRNA.OL Circio Holding ASA
0.9180
-3.37%
FLUI.ST Fluicell AB (publ)
0.0706
-1.94%
ACE.ST Ascelia Pharma AB (publ)
2.0850
-2.57%
BRNS Barinthus Biotherapeutics plc
1.4000
+5.26%
HNSA.ST Hansa Biopharma AB (publ)
32.32
-3.69%
VYNE VYNE Therapeutics Inc.
3.1400
-4.27%
ZURA Zura Bio Limited
4.3050
+4.74%